Overview
Isa Sayyeed Karim Mohammed is the director of refractive surgery and specializes in cornea, cataract and refractive surgery at the Wilmer Eye Institute, Johns Hopkins Medicine. He performs complex cataract surgery, corneal transplantation (penetrating keratoplasty, deep anterior lamellar keratoplasty, and descemet stripping automated endothelial keratoplasty and descemet membrane endothelial keratoplasty) and the entire range of refractive surgery, including laser-assisted in situ keratomileusis, photorefractive keratectomy and implantable collamer lenses surgery. Dr. Mohammed earned an undergraduate degree in biomedical engineering at The Johns Hopkins University and then received his medical doctorate from the University of Maryland School of Medicine. He completed an ophthalmology residency at the University of Maryland Medical Center, where he received both the Outstanding Resident Award and the Malouf Resident Research Award for excellence in research. He then completed more subspecialty training in cornea and refractive surgery at the renowned Cole Eye Institute at the Cleveland Clinic.
Dr. Mohammed is highly rated in 1 condition, according to our data. His clinical expertise encompasses Keratoconus, Interstitial Keratitis, Leber Hereditary Optic Neuropathy (LHON), and Embolectomy.
Dr. Mohammed is board certified in American Board Of Ophthalmology. He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10753 Falls Road, Pavilion II STE 455, Pavilion II STE 455, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.
Office
Janet Sunness is an Ophthalmologist practicing medicine in Towson, Maryland. Dr. Sunness is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).
The Johns Hopkins Hospital
Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.
Frequently Asked Questions about Dr. Isa S. Mohammed
How do I make an appointment with Dr. Isa S. Mohammed?
You can book an appointment with Dr. Isa S. Mohammed by calling their office at 410-583-2800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Isa S. Mohammed a top-rated expert for Embolectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Isa S. Mohammed is classified as an Advanced expert for Embolectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Isa S. Mohammed specialize in?
While Dr. Isa S. Mohammed is a Ophthalmology, they have specific expertise in Embolectomy, Keratoconus, and Interstitial Keratitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Isa S. Mohammed participate in research or clinical trials?
Yes. Dr. Isa S. Mohammed has published 11 articles and abstracts on conditions like Embolectomy. You can view a list of Dr. Isa S. Mohammed's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Isa S. Mohammed accept my insurance?
Dr. Isa S. Mohammed accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-583-2800 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EmbolectomyDr. Mohammed isAdvanced. Learn about Embolectomy.
- Experienced
- Interstitial KeratitisDr. Mohammed isExperienced. Learn about Interstitial Keratitis.
- KeratoconusDr. Mohammed isExperienced. Learn about Keratoconus.
- Leber Hereditary Optic Neuropathy (LHON)Dr. Mohammed isExperienced. Learn about Leber Hereditary Optic Neuropathy (LHON).